We collected information about Delcath Systems Inc Hours for you. Follow the liks to find out everything about Delcath Systems Inc Hours.
https://www.nasdaq.com/market-activity/stocks/dcth/after-hours
Delcath Systems, Inc. Common Stock (DCTH) After-Hours Stock Quotes - Nasdaq offers after-hours quotes and extended trading activity data for US and global markets.
https://www.nasdaq.com/market-activity/stocks/dcth
Aug 31, 2021 · Delcath Systems, Inc. Common Stock (DCTH) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.1 Year Target: $24.00
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=132392963
Jun 21, 2017 · Delcath Systems Secures Up to a $20.0 Million Debt Facility with Avenue Venture Opportunities Fund, L.P. GlobeNewswire Inc. - 8/9/2021 7:30:00 AM: Delcath Systems to Present at Upcoming Virtual Investor Conferences GlobeNewswire Inc. - 8/5/2021 9:00:00 AM
https://www.marketwatch.com/investing/stock/dcth
DCTH Complete Delcath Systems Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.1 Month: 19.87%
https://www.marketwatch.com/investing/stock/dcth/company-profile
Sep 08, 2021 · Delcath Systems Inc. Delcath Systems, Inc. is an oncology company, which focuses on the treatment of primary and metastatic liver cancers. It develops and commercializes CHEMOSAT and Melphalan ...Cash Ratio: 2.87
https://finance.yahoo.com/quote/DCTH/profile
Delcath Systems, Inc. was incorporated in 1988 and is headquartered in New York, New York. Corporate Governance Delcath Systems, Inc.’s ISS Governance QualityScore as of N/A is N/A.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=130180885
Apr 04, 2017 · Delcath Systems Inc. DCTH Stock Message Board: $DCTH After hours 178,625 $ .084 High!
https://finance.yahoo.com/quote/DCTH
Delcath Systems Announces Second Quarter 2021 Results. NEW YORK, Aug. 10, 2021 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment ...Ask: 0.00 x 1200
https://delcath.com/content/uploads/2020/01/DCTH-Corporate-Presentation-Jan-2020.pdf
Delcath Systems ♦ Interventional oncology (IO) company with multiple near term catalysts ♦ Enrollment completed ♦ Mid-2020 - Topline data expected ♦ Q1 2021 - FDA NDA submission for indication expected ♦ “IO is the Fourth pillar of Oncology treatment” - ASCO ♦ Competitors include Boston Scientific (BTG), Sirtex ♦ Proprietary IO system (PHP) designed to treat primary ...
Searching for Delcath Systems Inc Hours?
You can just click the links above. The info is collected for you.
